AI Science Tracker

Machine-guided synthetic regulatory DNA drives cell-type-specific expression across cell lines and vertebrates

Broad Institute of MIT and Harvard; The Jackson Laboratory; Yale University · 23 Oct 2024 · biology

Discovery

Machine-guided synthetic regulatory DNA drives cell-type-specific expression across cell lines and vertebrates

The CODA platform used the Malinois deep-learning model and sequence-search algorithms to design synthetic cis-regulatory elements (CREs). In massively parallel reporter assays, 94.1% of the synthetic sequences met the authors’ cell-type-specificity criterion, versus 73.6% of model-selected natural sequences and 40.6% of chromatin-mark-selected natural sequences; synthetic sequences also had higher measured target/off-target separation across K562, HepG2 and SK-N-SH cells. In transgenic zebrafish, two of three liver-directed and two of three neuron-directed CREs showed the intended activity. One neuron-directed sequence, synN1, retained cortical and neuronal expression in mice, including postnatal neocortical layer 6 and subplate neurons.

Technology: CODA (Computational Optimization of DNA Activity) with Malinois deep neural network and AdaLead, simulated annealing, and Fast SeqProp sequence search/design algorithms

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In massively parallel reporter assays, 94.1% of the synthetic sequences met the authors’ cell-type-specificity criterion, versus 73.6% of model-selected natural sequences and 40.6% of chromatin-mark-selected natural sequences; synthetic sequences also had higher measured target/off-target separation across K562, HepG2 and SK-N-SH cells.
  • Still unknown: The in-vitro work used three transformed human cell lines and reporter assays. In-vivo testing covered a small selected set: two of three liver-directed and two of three neuron-directed elements were active in zebrafish; mouse validation focused on neuronal synN1, with n=3 synN1 mice for postnatal cell-type analysis and n=6 for the 5-week cortical reporter assay. These are transgenic reporter results, not therapeutic delivery or evidence of clinical utility. Earlier synthetic enhancer studies existed; this paper’s counted result is its CODA/Malinois comparison against natural sequences plus selected vertebrate validation, not the general idea of AI-designed enhancers.
  • AI role: Malinois predicted MPRA activity of candidate DNA sequences in K562, HepG2 and SK-N-SH cells; CODA iteratively optimized sequences for specified cell-type specificity. Researchers synthesized and experimentally measured the designs by MPRA, then tested selected CREs with reporter constructs in zebrafish and mice. The paper attributes the novel sequences and their measured expression specificity to this model-guided design loop.

Evidence sources: https://www.nature.com/articles/s41586-024-08070-z

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 180 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.